-
1
-
-
0028015767
-
Behavioral science in translational research and cancer control
-
Morrow, G.R. and Bellg, A.J. (1994) Behavioral science in translational research and cancer control. Cancer 74 (Suppl.), 1409-1417
-
(1994)
Cancer
, vol.74
, Issue.SUPPL.
, pp. 1409-1417
-
-
Morrow, G.R.1
Bellg, A.J.2
-
2
-
-
38049096095
-
The meaning of translational research and why it matters
-
Woolf, S.H. (2008) The meaning of translational research and why it matters. JAMA 299, 211-213
-
(2008)
JAMA
, vol.299
, pp. 211-213
-
-
Woolf, S.H.1
-
3
-
-
85006134945
-
Translational research and the evolving landscape for biomedical innovation
-
Kaitin, K.I. (2012) Translational research and the evolving landscape for biomedical innovation. J. Investig. Med. 60, 995-998
-
(2012)
J. Investig. Med
, vol.60
, pp. 995-998
-
-
Kaitin, K.I.1
-
4
-
-
79961242544
-
Defining success for translational research organizations
-
Pozen, R. and Kline, H. (2011) Defining success for translational research organizations. Sci. Transl. Med. 3, 94cm20
-
(2011)
Sci. Transl. Med
, vol.3
-
-
Pozen, R.1
Kline, H.2
-
5
-
-
84866740453
-
Translational CNS medicines research
-
Palmer, A.M. and Alavijeh, M.S. (2012) Translational CNS medicines research. Drug Discov. Today 17, 1068-1078
-
(2012)
Drug Discov. Today
, vol.17
, pp. 1068-1078
-
-
Palmer, A.M.1
Alavijeh, M.S.2
-
6
-
-
33846583340
-
Hit and lead identification: Efficient practices for drug discovery
-
Goodnow, R.A., Jr and Gillespie, P. (2007) Hit and lead identification: efficient practices for drug discovery. Prog. Med. Chem. 45, 1-61
-
(2007)
Prog. Med. Chem
, vol.45
, pp. 1-61
-
-
Goodnow Jr., R.A.1
Gillespie, P.2
-
7
-
-
84860690620
-
Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survival
-
Morgan, P. et al. (2011) Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survival. Drug Discov. Today 17, 419-424
-
(2011)
Drug Discov. Today
, vol.17
, pp. 419-424
-
-
Morgan, P.1
-
8
-
-
77956454035
-
Medicines discovery in the 21st century: The case for a stakeholder corporation
-
Dixon, J. et al. (2010) Medicines discovery in the 21st century: the case for a stakeholder corporation. Drug Discov. Today 15, 700-703
-
(2010)
Drug Discov. Today
, vol.15
, pp. 700-703
-
-
Dixon, J.1
-
9
-
-
84864757410
-
Cystic fibrosis transmembrane conductance regulator-modifying medications: The future of cystic fibrosis treatment
-
Pettit, R.S. (2012) Cystic fibrosis transmembrane conductance regulator-modifying medications: the future of cystic fibrosis treatment. Ann. Pharmacother. 46, 1065- 1075
-
(2012)
Ann. Pharmacother
, vol.46
, pp. 1065-1075
-
-
Pettit, R.S.1
-
10
-
-
84857743319
-
Diagnosing the decline in pharmaceutical R&D efficiency
-
Scannell, J.W. et al. (2012) Diagnosing the decline in pharmaceutical R&D efficiency. Nat. Rev. Drug Discov. 11, 191-200
-
(2012)
Nat. Rev. Drug Discov
, vol.11
, pp. 191-200
-
-
Scannell, J.W.1
|